Venture Capital
Kintan Pty Ltd provides
early stage support to a small portfolio of early stage
technology companies. The support is generally
provided as a combination of expertise and capital for
specific activities,
such as intellectual property protection, that
helps establish a pathway to more substantial funding.
Investments in the enterprises are held by Kintan or
associated entities.
Kintan's current portfolio includes:
- Loke Goup Holdings Pty Ltd, an electronic payments and loyalty company;
- Havah Therapeutics, a biotechnology company developing a novel approach to breast cancer treatment;
- IRP Health Pty Ltd, a biotechnology company developing products that utilize natural, organic compounds as antibiotic alternatives for livestock;
- Wellend Health, clinics providing a large market of women the opportunity reduce their risk of breast cancer;
Kintan is not currently seeking additions to its portfolio.
News :
Havah Therapeutics
new patent application and grant
Havah Therapeutics in significant US clinical trial
Havah Therapeutics awarded significant US patent for
reducing breast cancer risk
